Market's view on Intelligent Ultrasound
Published on April 2024
- Expectations for updates on the company’s progress in the upcoming results announcement following recent fluctuations in share prices.
- Discussion of potential U.S. Department of Defense orders for field deployable ultrasound systems, specifically the NeedleTrainer 2 with the V Scan wireless ultrasound device.
- Insights on the launch of Intelligent Ultrasound’s Sonolyst software on GE Healthcare’s Voluson Signature Series, with a potential increase in machines using this technology to 10,000 per year.
- Notification of upcoming final results presentation and analyst briefing by Intelligent Ultrasound Group, with an open invitation for questions from investors.
- Recognition of the AI-enhanced Voluson Signature 20 and 18 ultrasound systems by GE Healthcare, highlighting advances in women’s health imaging.
- Discussion on the potential benefits of a new debt facility with HSBC, suggesting a move towards financial stability and flexibility for further investment.
- Speculation about the imminent launch of the Voluson Signature series and its impact on the company’s financial performance.
- Mention of a significant investment in Intelligent Ultrasound’s training systems by HQ.MED.ED for a rural healthcare project in Minnesota.
- Anticipation of financial results and the impact of avoiding further capital raises in maintaining company independence and shareholder value.
- Completion of the MIM deal by GEHC, with financial details pending.